GEN Exclusives

More »

Tutorials

More »
Jul 1, 2009 (Vol. 29, No. 13)

Expanding Disposable Depth-Filter Applications

Pall Focuses on the Improvement of Process Clarification Operations

  • The initial applications of single-use filtration products were for small-scale processes in laboratories where total process volumes were either quite small or exhibited low solids content. Today, single-use filtration systems are evolving quickly to address expanding applications, ranging from sterile filtration in final filling to the handling of hazardous or toxic products. Further, new frontiers such as virus filtration are leading the call for continued development.

    The cellulose-based Seitz® depth filter product line from Pall Life Sciences has undergone such a technological evolution. Specifically, the new Pall Stax™ single-use depth filter platform was developed to address the biopharmaceutical industry’s current and future demands.

  • Scalability

    Click Image To Enlarge +
    Figure 1. Pall Stax operating modes

    A vital requirement for any large-scale filtration system is that the performance scales up from development trials to commercial-scale production. Due to batch-to-batch variability and uncertainty in scale-up performance of a filtration solution, process developers typically apply a safety margin of 30% or greater for filtration area.

    Although allowing for process variability is a good engineering practice, adding additional filtration area based on uncertain scale-up performance leads to poor economics of the clarification step.

    In developing a design concept for a large-scale, single-use depth filter platform, Pall considered ease-of use and process aspects to derive a system design based on stacking depth-filter capsules vertically within a chassis. This design was preferred to that of a horizontal arrangement to aid installation, venting, and draining of the assembly as well as minimize the footprint needed.

    The design of the inlet/outlet manifold (distribution manifold) enables the greatest flexibility in the way the process-scale chassis can be operated (Figure 1). In bottom in/bottom out configuration, the process flow is through the distribution manifold at the bottom of the stack. The alternative operating mode of bottom in/top out or top in/bottom out allows for the process flow to enter and exit from opposite ends of the assembly.

    Switching between operating configurations is achieved by the simple addition or removal of the second distribution manifold at the top of the stack. The use of the bottom in/top out or top in/bottom out operating mode is potentially applicable for large area, single-layer systems operated at high feed flow flux rates and/or for ease of product handling. The bottom in/bottom out operating mode will otherwise apply.

    Additionally the design of the Pall Stax platform provides users with the flexibility to operate the stack in a serial flow mode, whereby two grades of filter media can be operated in series within one chassis. Furthermore, because of the small footprint, multiple chassis can be placed into a small area.

    Filterability trials were conducted to assess the scalability of the Stax platform. The trials focused on operating with single-layer modules, which require a higher feed flow rate through the filter assembly than double layer filters, and will amplify the effect of any hydrodynamic losses through the filter assembly. This provided for the worst-case scenario.

    The test program included a comparison of the performance of the Pall Stax assembly with other Pall sheet filter formats to provide scalability data across the product range.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Alzheimer's Therapies

Do you think an effective treatment for Alzheimer’s will be found within the next 10–15 years?